← Product Code [IPF](/submissions/PM/subpart-f%E2%80%94physical-medicine-therapeutic-devices/IPF) · K020684

# FINESUN EMS STIMULATOR (K020684)

_Finesun Worldwide Intl. Co., Ltd. · IPF · May 23, 2002 · Physical Medicine · SESE_

**Canonical URL:** https://fda.innolitics.com/submissions/PM/subpart-f%E2%80%94physical-medicine-therapeutic-devices/IPF/K020684

## Device Facts

- **Applicant:** Finesun Worldwide Intl. Co., Ltd.
- **Product Code:** [IPF](/submissions/PM/subpart-f%E2%80%94physical-medicine-therapeutic-devices/IPF.md)
- **Decision Date:** May 23, 2002
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 890.5850
- **Device Class:** Class 2
- **Review Panel:** Physical Medicine
- **Attributes:** Therapeutic

## Indications for Use

For model FS-004 - Relaxation of muscle spasms . For models FS-008, FS-012, FS-016 and FS-020 - Relaxation of muscle spasms . - Prevention or retardation of disuse atrophy . - Increasing local blood circulation . - Muscle re-education . - Immediate post-surgical stimulation of calf muscles . to prevent venous thrombosis - Maintaining or increasing range of motion .

## Device Story

Finesun EMS Stimulator (Models FS-004, FS-008, FS-012, FS-016, FS-020) is a powered muscle stimulator. Device delivers electrical impulses to muscles via electrodes to induce contraction. Used for muscle spasm relaxation, atrophy prevention, blood circulation improvement, muscle re-education, post-surgical venous thrombosis prevention, and range of motion maintenance. Operated by healthcare professionals or patients (depending on prescription/OTC status). Output is electrical stimulation; clinical benefit is improved muscle function and circulation.

## Clinical Evidence

No clinical data provided; substantial equivalence determination based on technological characteristics and intended use compared to legally marketed predicate devices.

## Technological Characteristics

Powered muscle stimulator (21 CFR 890.5850). Device utilizes electrical stimulation for muscle contraction. Models vary by channel/output configuration (FS-004 through FS-020).

## Regulatory Identification

A powered muscle stimulator is an electrically powered device intended for medical purposes that repeatedly contracts muscles by passing electrical currents through electrodes contacting the affected body area.

## Submission Summary (Full Text)

> This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com.
>
> Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/).

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized caduceus symbol, which is a staff with two snakes coiled around it, and the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" arranged in a circular fashion around the symbol. The logo is black and white.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

FEB 2 1 2008

Finesun Worldwide Int'l Co., Ltd. % Chi-Chu Wu Chen New Century Technology 3F, No. 31, Hu-Pin Road #1 Hsin-Chu, Taiwan

Re: K020684

Trade/Device Name: Finesun EMS Stimulator, Models FS-004, FS-008, FS-012, FS-016 and FS-020 Regulation Number: 21 CFR 890.5850 Regulation Name: Powered muscle stimulator Regulatory Class: II Product Code: IPF Dated: February 27, 2002 Received: March 4, 2002

Dear Mr. Chen:

This letter corrects our substantially equivalent letter of May 23, 2002.

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate for associated in the May 28, 1976, the enactment date of the Medical Device Amendments, or to eonimered prox to 110 - 110 - 120 - 120 - 12 - 12 - 11 - 11 - Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The r ou may attress, and include requirements for annual registration, listing of general controls provision practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it ir your device to such additional controls. Existing major regulations affecting your device can may be subject to back as one as a may be marts 800 to 898. In addition, FDA may be round in ther over ents concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean r lease oe actives and I Drivision that your device complies with other requirements of the Act that 1 Dr Has Intactions and regulations administered by other Federal agencies. You must or any I edelar status and including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set CI K Fart 007); idocime (21 CFR Part 820); and if applicable, the electronic form in the quany by overs of provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

{1}------------------------------------------------

Page 2 -- Chi-Chu Wu Chen

This letter will allow you to continue marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at (240) 276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at (240) 276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

Mark N. Millman

Mark N. Melkerson Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

## 3.0 INDICATIONS FOR USE STATEMENT

510(k) Number (if know)

Finesun EMS Stimulator Device Name

Indications for Use:

For model FS-004

- Relaxation of muscle spasms ●
For models FS-008, FS-012, FS-016 and FS-020

- Relaxation of muscle spasms .
- Prevention or retardation of disuse atrophy .
- Increasing local blood circulation ●
- Muscle re-education ●
- Immediate post-surgical stimulation of calf muscles . to prevent venous thrombosis
- Maintaining or increasing range of motion .

PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED

Concurrence of CDRH, Office of Device Evaluation (ODE)

or

Prescription Use (Per 21 CFR 801.109) Over -The-Counter Use_

for Mark N. Milken
(Division Sign Off)

ion of General, Restorative Neurological Devices

510(k) Number K020684

---

**Source:** [https://fda.innolitics.com/submissions/PM/subpart-f%E2%80%94physical-medicine-therapeutic-devices/IPF/K020684](https://fda.innolitics.com/submissions/PM/subpart-f%E2%80%94physical-medicine-therapeutic-devices/IPF/K020684)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com
